INCREASED DOSE INTENSITY (DI) OF DOXORUBICIN AND VINBLASTINE DURING ABVD THERAPY OF HODGKINS LYMPHOMA WITH THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF)
K. Raybon et al., INCREASED DOSE INTENSITY (DI) OF DOXORUBICIN AND VINBLASTINE DURING ABVD THERAPY OF HODGKINS LYMPHOMA WITH THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF), Blood, 86(10), 1995, pp. 3270-3270